131 related articles for article (PubMed ID: 28429228)
1. Magnetic Resonance Imaging of Tumors with the Use of Iron Oxide Magnetic Nanoparticles as a Contrast Agent.
Semkina AS; Abakumov MA; Grinenko NF; Lipengolts AA; Nukolova NV; Chekhonin VP
Bull Exp Biol Med; 2017 Apr; 162(6):808-811. PubMed ID: 28429228
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the Size of Magnetic Nanoparticles and Efficiency of MRT Imaging of Cerebral Glioma in Rats.
Semkina AS; Abakumov MA; Abakumov AM; Nukolova NV; Chekhonin VP
Bull Exp Biol Med; 2016 Jun; 161(2):292-5. PubMed ID: 27383161
[TBL] [Abstract][Full Text] [Related]
3. VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor.
Abakumov MA; Nukolova NV; Sokolsky-Papkov M; Shein SA; Sandalova TO; Vishwasrao HM; Grinenko NF; Gubsky IL; Abakumov AM; Kabanov AV; Chekhonin VP
Nanomedicine; 2015 May; 11(4):825-33. PubMed ID: 25652902
[TBL] [Abstract][Full Text] [Related]
4. Iron oxide nanoparticle surface decorated with cRGD peptides for magnetic resonance imaging of brain tumors.
Richard S; Boucher M; Lalatonne Y; Mériaux S; Motte L
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1515-1520. PubMed ID: 28017683
[TBL] [Abstract][Full Text] [Related]
5. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
Shan X; Yuan D; Xiong F; Gu N; Wang P
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
[TBL] [Abstract][Full Text] [Related]
6. RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas.
Luo Y; Yang J; Yan Y; Li J; Shen M; Zhang G; Mignani S; Shi X
Nanoscale; 2015 Sep; 7(34):14538-46. PubMed ID: 26260703
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
Gao WH; Liu ST; Fan CX; Qi LY; Chen ZL
Yao Xue Xue Bao; 2011 Jul; 46(7):845-51. PubMed ID: 22010356
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of tumor-targeted folate conjugated fluorescent magnetic albumin nanoparticles for enhanced intracellular dual-modal imaging into human brain tumor cells.
Wang X; Tu M; Tian B; Yi Y; Wei Z; Wei F
Anal Biochem; 2016 Nov; 512():8-17. PubMed ID: 27523645
[TBL] [Abstract][Full Text] [Related]
9. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
10. Molecular Targeted Magnetic Resonance Imaging of Human Colorectal Carcinoma (LoVo) Cells Using Novel Superparamagnetic Iron Oxide- Loaded Nanovesicles: In Vitro and in vivo Studies.
Feng ST; Li H; Luo Y; Cai H; Dong Z; Fang Z; Shuai X; Li ZP
Curr Cancer Drug Targets; 2016; 16(6):551-60. PubMed ID: 27262319
[TBL] [Abstract][Full Text] [Related]
11. Biocompatible Low-Retention Superparamagnetic Iron Oxide Nanoclusters as Contrast Agents for Magnetic Resonance Imaging of Liver Tumor.
Wei Y; Liao R; Liu H; Li H; Xu H; Zhou Q
J Biomed Nanotechnol; 2015 May; 11(5):854-64. PubMed ID: 26349397
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma.
Shevtsov MA; Nikolaev BP; Yakovleva LY; Dobrodumov AV; Zhakhov AV; Mikhrina AL; Pitkin E; Parr MA; Rolich VI; Simbircev AS; Ischenko AM
Neoplasia; 2015 Jan; 17(1):32-42. PubMed ID: 25622897
[TBL] [Abstract][Full Text] [Related]
13. [MRI monitoring ultra-small superparamagnetic iron oxide (USPIO) particle labeling C6 rat glioma cells].
Zhang GX; Li YJ; Zhang F; Zhao JL; Li KA; Hu YS
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):228-32. PubMed ID: 17425864
[TBL] [Abstract][Full Text] [Related]
14. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
16. Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.
Liu H; Zhang J; Chen X; Du XS; Zhang JL; Liu G; Zhang WG
Nanoscale; 2016 Apr; 8(15):7808-26. PubMed ID: 27029509
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma.
Shevtsov MA; Yakovleva LY; Nikolaev BP; Marchenko YY; Dobrodumov AV; Onokhin KV; Onokhina YS; Selkov SA; Mikhrina AL; Guzhova IV; Martynova MG; Bystrova OA; Ischenko AM; Margulis BA
Neuro Oncol; 2014 Jan; 16(1):38-49. PubMed ID: 24305705
[TBL] [Abstract][Full Text] [Related]
18. Imaging Tumor Necrosis with Ferumoxytol.
Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
[TBL] [Abstract][Full Text] [Related]
19. Molecular susceptibility weighted imaging of the glioma rim in a mouse model.
Blasiak B; Landry J; Tyson R; Sharp J; Iqbal U; Abulrob A; Rushforth D; Matyas J; Ponjevic D; Sutherland GR; Wolfsberger S; Tomanek B
J Neurosci Methods; 2014 Apr; 226():132-138. PubMed ID: 24525326
[TBL] [Abstract][Full Text] [Related]
20. In vivo magnetic resonance imaging tracking of C6 glioma cells labeled with superparamagnetic iron oxide nanoparticles.
Mamani JB; Malheiros JM; Cardoso EF; Tannús A; Silveira PH; Gamarra LF
Einstein (Sao Paulo); 2012; 10(2):164-70. PubMed ID: 23052451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
